Bavarian Nordic lifts FY2026 revenue outlook to about DKK 6.1 billion, raises EBITDA margin view to about 32%

• Bavarian Nordic lifted full-year 2026 guidance, targeting revenue of about DKK 6.1 billion.
• Travel Health forecast raised to about DKK 3.4 billion from about DKK 3.0 billion on stronger rabies vaccine demand.
• Higher U.S. animal rabies activity drove more human exposure, boosting pre- and post-exposure vaccination sales.
• Public Preparedness outlook maintained at about DKK 2.5 billion, with about DKK 2.4 billion already secured in orders.
• EBITDA margin expected at about 32%, up from about 30% in the prior outlook.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bavarian Nordic A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080143OMX_____CNEWS_EN_GNW1001276895_en) on October 08, 2026, and is solely responsible for the information contained therein.